Microplastics and Misinformation: What Science Really Says
November 12, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Lumify, alphagan P,Qoliana
Synonyms :
brimonidine
Class :
Antiglaucoma
Brand Name :
Lumify, alphagan P,Qoliana
Synonyms :
brimonidine
Class :
Antiglaucoma
Dosage Forms & StrengthsÂ
Ophthalmic solution (Rx)Â
0.15%Â
0.1%Â
Elevated Intraocular PressureÂ
One drop in the affected eye every 8 hours
Administer one drop in each affected eye every 6-8 hours
Dosage Forms & StrengthsÂ
Ophthalmic solution (Rx)Â
0.15%Â
0.1%Â
Elevated Intraocular PressureÂ
<2 years: Contraindicated >2 years: 1 drop in the affected eye every 8 hours
<5 years: Safety and efficacy not established >5 years: Administer one drop in each affected eye every 6-8 hours
Refer adult dosingÂ
brimonidine: they may enhance the serum concentration of CYP2D6 Inhibitors
brimonidine: they may enhance the serum concentration of CYP2D6 Inhibitors
brimonidine: they may enhance the serum concentration of CYP2D6 Inhibitors
brimonidine: they may enhance the serum concentration of CYP2D6 Inhibitors
brimonidine: they may enhance the serum concentration of CYP2D6 Inhibitors
It may enhance sedation when combined with oxycodone
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the hypotensive effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the toxic effect
may increase the toxic effect
may increase the toxic effect
may increase the toxic effect
may increase the toxic effect
may increase the bradycardiac effect
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
may have an increased Effect of a CNS depressant when combined with CNS depressants
may have an increased Effect of a CNS depressant when combined with CNS depressants
may have an increased Effect of a CNS depressant when combined with CNS depressants
brimonidine and triprolidine lead to increased sedative effects
brimonidine: they may increase the hypotensive effect when combined with blood viscosity-reducing agents
brimonidine: they may increase the hypotensive effect when combined with blood viscosity-reducing agents
may have an increased hypotensive effect when combined with antihypertensive agents
brimonidine: they may diminish the serum concentration of CYP3A4 Inducers
brimonidine: they may diminish the serum concentration of CYP3A4 Inducers
brimonidine: they may diminish the serum concentration of CYP3A4 Inducers
brimonidine: they may diminish the serum concentration of CYP3A4 Inducers
brimonidine: they may diminish the serum concentration of CYP3A4 Inducers
brimonidine: it may increase the central nervous system depressant activities of tolperisone
brimonidine: it may increase the antihypertensive activities of phentolamine
may increase the toxic effect
may increase the CNS depressant effect
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the hypotensive effect of Blood Pressure Lowering Agents
may increase the CNS depressant effect of CNS Depressants
amiodarone: they may enhance the serum concentration of brimonidine
an increase in CNS depressant activity may be seen
Frequency not defined:Â Â
Conjunctival hyperemiaÂ
Eye pruritisÂ
PhotophobiaÂ
FatigueÂ
DyspepsiaÂ
Eye dischargeÂ
Oral drynessÂ
Allergic conjunctivitisÂ
RashÂ
HeadacheÂ
DizzinessÂ
BlepharitisÂ
Pregnancy consideration: BÂ
Lactation: Excretion of the drug in human breast milk is unknown Â
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Patient information leafletÂ
Generic Name: brimonidineÂ
Pronounced: ( bri-moni-dine)Â
Why do we use brimonidine?Â
It is used to treat ocular hypertension and glaucomaÂ
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
